Business Context and Reporting Period
This Form 8-K is a current report filed by Capricor Therapeutics, Inc. on December 4, 2013. The filing serves as a Regulation FD disclosure regarding an upcoming investor presentation by the company's Chief Executive Officer, Dr. Linda Marbán.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a notice of a corporate event and does not contain financial statements or performance data.
Material Changes
No material changes to financial condition or operations are reported in this filing. The document solely announces a scheduled conference presentation.
Guidance, Outlook, and Management Commentary
- Event: Dr. Linda Marbán, CEO, is scheduled to present at the Piper Jaffray 25th Annual Healthcare Conference.
- Time and Location: Approximately 1:30 p.m. Eastern time at the New York Palace Hotel in New York City.
- Access: A webcast of the presentation is available on the "Investors" section of the company website (www.capricor.com).
- Materials: Presentation slides are available on the website and will be archived for at least 30 days.
- Legal Status: The information furnished is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the availability of the webcast and presentation slides on the company's investor relations website.
- Review the content of the presentation slides for any new operational updates or strategic shifts not detailed in this 8-K.
- Check subsequent filings (e.g., 10-Q or 10-K) for the actual financial metrics and performance data, as they are absent from this report.